[ Price : $8.95]
FDA approves a bioLytical Laboratories PMA for the INSTI HIV Self Test, an at-home HIV test that delivers results in 60 seconds or...[ Price : $8.95]
FDA accepts for review a Chiesi NDA for a single-inhaler triple therapy designed for the maintenance treatment of asthma in adults...[ Price : $8.95]
Charles River Laboratories names former FDA principal deputy commissioner Namandj N. Bumpus as chair a new global scientific advis...[ Price : $8.95]
FDA warns of serious complications associated with certain uses of radiofrequency microneedling devices, commonly used in aestheti...[ Price : $8.95]
FDA warns Nesconset, NY-based LifeVac that it is illegally marketing and distributing an airway clearance device.[ Price : $8.95]
FDA accepts for review a Cingulate NDA for CTx-1301 (dexmethylphenidate), a once-daily stimulant designed to treat attention-defic...[ Price : $8.95]
An Astellas Phase 2 study evaluating zolbetuximab in combination with standard chemotherapy for metastatic pancreatic cancer fails...[ Price : $8.95]
FDA publishes a guidance with recommendations for submitting clinical trial data sets for response assessments for treatments of a...